Maria E Johansson1, Marcus A Ulleryd2, Angelina Bernardi2, Anna M Lundberg2, Annica Andersson2, Lasse Folkersen2, Linda Fogelstrand2, Ulrika Islander2, Zhong-Qun Yan2, Göran K Hansson2. 1. From the Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden (M.E.J., A.M.L., L.Folkersen, Z.-q.Y., G.K.H.); and Department of Physiology, Institute of Neuroscience and Physiology (M.E.J., M.A.U.), Department of Rheumatology and Inflammation Research, Institute of Medicine (A.B., A.A., U.I.), and Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine (L.Fogelstrand), The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. maria.e.johansson@neuro.gu.se. 2. From the Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden (M.E.J., A.M.L., L.Folkersen, Z.-q.Y., G.K.H.); and Department of Physiology, Institute of Neuroscience and Physiology (M.E.J., M.A.U.), Department of Rheumatology and Inflammation Research, Institute of Medicine (A.B., A.A., U.I.), and Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine (L.Fogelstrand), The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Abstract
OBJECTIVE: Cholinergic pathways of the autonomic nervous system are known to modulate inflammation. Because atherosclerosis is a chronic inflammatory condition, we tested whether cholinergic signaling operates in this disease. We have analyzed the expression of the α7 nicotinic acetylcholine receptor (α7nAChR) in human atherosclerotic plaques and studied its effects on the development of atherosclerosis in the hypercholesterolemic Ldlr(-/-) mouse model. APPROACH AND RESULTS: α7nAChR protein was detected on T cells and macrophages in surgical specimens of human atherosclerotic plaques. To study the role of α7nAChR signaling in atherosclerosis, male Ldlr(-/-) mice were lethally irradiated and reconstituted with bone marrow from wild-type or α7nAChR-deficient animals. Ablation of hematopoietic cell α7nAChR increased aortic atherosclerosis by 72%. This was accompanied by increased aortic interferon-γ mRNA, implying increased Th1 activity in the absence of α7nAChR signaling. CONCLUSIONS: The present study shows that signaling through hematopoietic α7nAChR inhibits atherosclerosis and suggests that it operates by modulating immune inflammation. Given the observation that α7nAChR is expressed by T cells and macrophages in human plaques, our findings support the notion that cholinergic regulation may act to inhibit disease development also in man.
OBJECTIVE: Cholinergic pathways of the autonomic nervous system are known to modulate inflammation. Because atherosclerosis is a chronic inflammatory condition, we tested whether cholinergic signaling operates in this disease. We have analyzed the expression of the α7 nicotinic acetylcholine receptor (α7nAChR) in humanatherosclerotic plaques and studied its effects on the development of atherosclerosis in the hypercholesterolemicLdlr(-/-) mouse model. APPROACH AND RESULTS: α7nAChR protein was detected on T cells and macrophages in surgical specimens of humanatherosclerotic plaques. To study the role of α7nAChR signaling in atherosclerosis, male Ldlr(-/-) mice were lethally irradiated and reconstituted with bone marrow from wild-type or α7nAChR-deficient animals. Ablation of hematopoietic cell α7nAChR increased aortic atherosclerosis by 72%. This was accompanied by increased aortic interferon-γ mRNA, implying increased Th1 activity in the absence of α7nAChR signaling. CONCLUSIONS: The present study shows that signaling through hematopoietic α7nAChR inhibits atherosclerosis and suggests that it operates by modulating immune inflammation. Given the observation that α7nAChR is expressed by T cells and macrophages in human plaques, our findings support the notion that cholinergic regulation may act to inhibit disease development also in man.
Authors: April S Caravaca; Alessandro L Gallina; Laura Tarnawski; Vladimir S Shavva; Romain A Colas; Jesmond Dalli; Stephen G Malin; Henrik Hult; Hildur Arnardottir; Peder S Olofsson Journal: Proc Natl Acad Sci U S A Date: 2022-05-27 Impact factor: 12.779
Authors: Uriya Bekenstein; Nibha Mishra; Dan Z Milikovsky; Geula Hanin; Daniel Zelig; Liron Sheintuch; Amit Berson; David S Greenberg; Alon Friedman; Hermona Soreq Journal: Proc Natl Acad Sci U S A Date: 2017-06-05 Impact factor: 11.205
Authors: Gunnar Engström; Viktor Hamrefors; Artur Fedorowski; Anders Persson; Maria E Johansson; Ellen Ostenfeld; Isabel Goncalves; Hanna Markstad; Linda S B Johnson; Margaretha Persson; Jonas Carlson; Pyotr G Platonov Journal: J Am Heart Assoc Date: 2022-03-30 Impact factor: 6.106
Authors: Maria E Hammarlund; C Joakim Ek; Sukaina Akar; Alma Karlsson; Bagmi Pattanaik; Filip Mjörnstedt; Pernilla Svedin; Maryam Ardalan; Eridan Rocha-Ferreira; Carina Mallard; Maria E Johansson Journal: Biomedicines Date: 2022-08-19
Authors: Maria E Hammarlund; Vladimer Darsalia; Filip Mjörnstedt; Bagmi Pattanaik; Carina Mallard; Eridan Rocha-Ferreira; Cesare Patrone; Maria E Johansson Journal: Biosci Rep Date: 2021-06-25 Impact factor: 3.840